Exposure to Mosquito-Transmitted Dengue May Provide Immunity Against COVID-19
|
By HospiMedica International staff writers Posted on 25 Sep 2020 |
|
Illustration
A study has found a link between the spread of the SARS-CoV-2 virus and previous outbreaks of dengue fever in Brazil, suggesting that exposure to the mosquito-transmitted illness could provide some immunity against COVID-19.
The study found a significant correlation between lower incidence, mortality and growth rate of COVID-19 among the Brazilian population that had higher levels of antibodies to dengue. In the study that has not yet been published by the Duke University (Durham, NC, USA) but shared exclusively with Reuters, researchers compared the geographic distribution of coronavirus cases with the spread of dengue in 2019 and 2020. They found that locations that had witnessed intense dengue outbreaks in 2020 or 2019 reported lower coronavirus infection rates and a slower increase in the number of COVID-19 cases. “This striking finding raises the intriguing possibility of an immunological cross-reactivity between dengue’s Flavivirus serotypes and SARS-CoV-2,” according to the study, referring to dengue virus antibodies and the novel coronavirus. “If proven correct, this hypothesis could mean that dengue infection or immunization with an efficacious and safe dengue vaccine could produce some level of immunological protection” against SARS-CoV-2, it added.
Miguel Nicolelis, a professor at Duke University who led the study, told Reuters that the results were especially interesting given that previous studies had shown that it was possible for people with dengue antibodies in their blood to test falsely positive for COVID-19 antibodies despite never being infected by the coronavirus. The researchers found a similar relationship between dengue outbreaks and a slower spread of COVID-19 in other parts of Latin America, as well as Asia and islands in the Pacific and Indian Oceans, according to Reuters.
“This indicates that there is an immunological interaction between two viruses that nobody could have expected, because the two viruses are from completely different families,” Nicolelis told Reuters, adding that further studies are needed to prove the connection.
Related Links:
Duke University
The study found a significant correlation between lower incidence, mortality and growth rate of COVID-19 among the Brazilian population that had higher levels of antibodies to dengue. In the study that has not yet been published by the Duke University (Durham, NC, USA) but shared exclusively with Reuters, researchers compared the geographic distribution of coronavirus cases with the spread of dengue in 2019 and 2020. They found that locations that had witnessed intense dengue outbreaks in 2020 or 2019 reported lower coronavirus infection rates and a slower increase in the number of COVID-19 cases. “This striking finding raises the intriguing possibility of an immunological cross-reactivity between dengue’s Flavivirus serotypes and SARS-CoV-2,” according to the study, referring to dengue virus antibodies and the novel coronavirus. “If proven correct, this hypothesis could mean that dengue infection or immunization with an efficacious and safe dengue vaccine could produce some level of immunological protection” against SARS-CoV-2, it added.
Miguel Nicolelis, a professor at Duke University who led the study, told Reuters that the results were especially interesting given that previous studies had shown that it was possible for people with dengue antibodies in their blood to test falsely positive for COVID-19 antibodies despite never being infected by the coronavirus. The researchers found a similar relationship between dengue outbreaks and a slower spread of COVID-19 in other parts of Latin America, as well as Asia and islands in the Pacific and Indian Oceans, according to Reuters.
“This indicates that there is an immunological interaction between two viruses that nobody could have expected, because the two viruses are from completely different families,” Nicolelis told Reuters, adding that further studies are needed to prove the connection.
Related Links:
Duke University
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Patient Preoperative Skin Preparation
BD ChloraPrep
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
